Sadness as Diagnosis: Why America Has Turned to Antidepressants

In the United States, one in six adults now takes antidepressants, a statistic that has ignited fierce debate. Critics, including some medical professionals and politicians, contend that these medications are being overprescribed, leading to a crisis of overdiagnosis. However, a closer examination of the data suggests that the issue runs deeper than individual physician error, pointing instead to a systemic failure within the nation's healthcare system. The Blurring Line Between Sadness and Sickness Selective serotonin reuptake inhibitors (SSRIs), the most common class of antidepressants, are generally indicated for moderate to severe depression according to established medical standards. For milder cases, the risk of side effects often outweighs the potential benefits, and non-pharmacological interventions such as psychotherapy can be equally effective. The core of the problem lies in the ambiguity of diagnostic definitions. The everyday understanding of "depression" often conflates temporary sadness with a clinical disorder. Primary care physicians frequently rely on screening questionnaires that, while useful for identifying potential issues, cannot substitute for a comprehensive diagnostic evaluation. This can lead to critical errors in both directions: one patient may receive an unnecessary prescription after a couple of weeks of feeling down, while another, facing a genuine risk of suicide, might be left without the help they desperately need. The grim reality is that over a third of individuals who die by suicide had consulted a primary care physician within the month preceding their death, a figure that rises to over 66% for those aged 55 and older. Why General Practitioners Prescribe Antidepressants Data from 2026 confirms that the majority of antidepressant prescriptions in the U.S. are issued by general practitioners, not by psychiatrists. This trend is driven by a confluence of three key factors: